WHO-GMP certification granted to Taj Pharma's formulations manufacturing plant
WHO-GMP certification

Taj Pharma, an India-based multinational pharmaceutical company, stands as a trusted global partner in the development, manufacturing, and licensing of value-added Oral Solid Dosage (OSD) forms. With a robust workforce of 500+ skilled professionals and cutting-edge factories and R&D centers in India and France, Taj Pharma delivers high-quality, affordable, and innovative medicines across major therapeutic segments such as CNS, Cardio-Metabolic, Gastroenterology, Gynecology, Pain Management, and Glucocorticoids.

Our strong commitment to research-driven innovation, combined with compliance to international regulatory standards, positions Taj Pharma as one of the most reliable and progressive pharmaceutical manufacturers in the world.


World-Class R&D and Manufacturing Capabilities

Taj Pharma operates on a global scale, leveraging a dual strategy of research innovation and manufacturing excellence. Our facilities are WHO-GMP, PIC/S, ISO, and GLP compliant, ensuring stringent quality control at every stage. With advanced formulation development laboratories in India and France, we focus on:

  • Developing value-added OSD formulations
  • Enhancing patient compliance with innovative delivery systems
  • Licensing global standard products to regulated and emerging markets
  • Collaborating with international partners for branded and generic product development

Our global reach extends to Europe, Latin America, Africa, Asia, and the Middle East, ensuring healthcare access through affordable and effective medicines.

KEY PRODUCTS:

Bilastine 10 & 20 mgODT/TabletAllergyBilaska® 20mg Tablet Menarini/Faes France
Esomeprazole 20 & 40 mgCapsuleGastroenterologyInexium® Tablet AstraZeneca France
Etifoxine 50 mgCapsuleCNSStresam® Biocodex France
Fenofibrate 67, 200, 267 mg/160 mgCapsule/TabletCardio MetabolicLipanthyl® Abbott France/ Lipanthyl® Abbott UK
Josamycin125, 250 mg/ 500mgSachet/TabletAntibioticJosacine® 500mg/5ml /500mg Tablet Astellas France
Ketorolac10 mgSL TabletPain / Anti-InflammatoryToragesic®
Lysdexamphetamine 10 to 70mgODTCNSVyvanse® Tablet Brazil & Germany  
Mesalamine Sachet1 & 2 gSachetGastroenterologyPentasa® 2 gms Ferring France
Ondansetron4 & 8 mgODTAnti-emeticZofren® ODT GSK UK, GSK Canada
Prednisolone 1, 5mg/5, 10 mgODT/Sol TabletAnti-InflammatoryPrednesol Tablets 5mg, Concordia UK
Racecadotril 10 & 30 mgSachetGastroenterologyTiorfan® Bioprojet France
Secnidazole 2 gSachetGynaecologySecnol® Iprad France
Tranexamic Acid 1 gSachetGynaecologyCyklo F® Viatris NL
Trazodone75 & 150 mgScored TabletCNSTrittico SR BID
Zolpidem5 & 10 mgODT/SL TabletCNSStilnox® Sanofi France/ Sublinox® Valeant Canada, Patz® Brazil

Therapeutic Segments Covered by Taj Pharma

We focus on some of the most critical therapeutic areas, ensuring that our portfolio meets global demand for essential and innovative medicines.

1. Central Nervous System (CNS)

Taj Pharma delivers advanced CNS formulations targeting neurological disorders, anxiety, depression, sleep disorders, and attention-related conditions.

Key CNS Products:

  • Etifoxine 50mg Capsule – Marketed under Stresam® (Biocodex France), used in the treatment of anxiety disorders.
  • Lysdexamphetamine (10–70 mg ODT) – Equivalent to Vyvanse® in Brazil & Germany, for ADHD management.
  • Trazodone 75 & 150mg Tablet – Extended release (Trittico SR BID) for depression and insomnia.
  • Zolpidem 5 & 10mg ODT/SL Tablet – Equivalent to Stilnox® (Sanofi France), Sublinox® (Valeant Canada), Patz® (Brazil), indicated for insomnia treatment.

2. Cardio-Metabolic

Our portfolio addresses the growing global demand for effective cholesterol-lowering and lipid-regulating drugs.

Key Cardio-Metabolic Products:

  • Fenofibrate (67, 200, 267, 160 mg Capsules/Tablets) – Equivalent to Lipanthyl® (Abbott France/UK), used in hyperlipidemia and cardiovascular risk reduction.

3. Gastroenterology

Taj Pharma offers a wide range of gastrointestinal medicines, with proven efficacy in acid suppression, IBD management, anti-diarrheal therapies, and antiemetic formulations.

Key Gastroenterology Products:

  • Esomeprazole 20 & 40mg Capsules – Equivalent to Inexium® (AstraZeneca France), for acid reflux and GERD.
  • Mesalamine Sachets (1 & 2 g) – Equivalent to Pentasa® (Ferring France), effective in ulcerative colitis and Crohn’s disease.
  • Racecadotril (10 & 30 mg Sachets) – Equivalent to Tiorfan® (Bioprojet France), for acute diarrhea management.
  • Ondansetron (4 & 8 mg ODT) – Equivalent to Zofren® (GSK UK/Canada), used as an anti-emetic for chemotherapy and post-surgery patients.

4. Gynecology

With a focus on women’s health, Taj Pharma develops high-quality formulations to address gynecological conditions.

Key Gynecology Products:

  • Secnidazole 2g Sachet – Equivalent to Secnol® (Iprad France), indicated for vaginal infections.
  • Tranexamic Acid 1g Sachet – Equivalent to Cyklo F® (Viatris NL), used for heavy menstrual bleeding.

5. Pain Management and Anti-Inflammatory

Pain relief is one of the most demanding therapeutic areas, and Taj Pharma offers innovative delivery formats for improved patient compliance.

Key Pain Management Products:

  • Ketorolac 10mg SL Tablet – Equivalent to Toragesic®, for acute moderate-to-severe pain relief.
  • Prednisolone (1, 5mg/5, 10 mg ODT/Sol Tablets) – Equivalent to Prednesol (Concordia UK), used as an anti-inflammatory and immunosuppressant therapy.

6. Antibiotics

Taj Pharma continues to strengthen its antibiotic range, supplying essential medicines across regulated and emerging markets.

Key Antibiotic Products:

  • Josamycin (125, 250, 500 mg Sachet/Tablet) – Equivalent to Josacine® (Astellas France), used for bacterial respiratory and soft tissue infections.

7. Allergy Management

Our anti-allergy portfolio brings patient-centric solutions with fast-acting formulations.

Key Allergy Products:

  • Bilastine (10 & 20mg ODT/Tablet) – Equivalent to Bilaska® (Menarini/Faes France), used for allergic rhinitis and urticaria.

Strategic Partnerships and Licensing Collaborations

Taj Pharma collaborates with leading multinational pharmaceutical companies to co-develop, license, and distribute high-value OSD products globally. With strong product equivalence to internationally recognized brands, we offer partnering opportunities in licensing, technology transfers, and co-marketing.

Examples of licensed collaborations include:

  • Bilaska® with Menarini/Faes France
  • Inexium® with AstraZeneca France
  • Lipanthyl® with Abbott France & UK
  • Zofren® with GSK UK & Canada
  • Stilnox® with Sanofi France

Why Choose Taj Pharma as Your Global Pharmaceutical Partner?

  • 500+ expert professionals across India and France.
  • Regulatory compliant facilities with WHO-GMP, PIC/S, GLP, and ISO certifications.
  • Rich OSD product portfolio across multiple therapeutic segments.
  • Proven track record with licensing and partnerships with global innovators.
  • Competitive pricing and reliable supply chain for both regulated and emerging markets.

Global Reach and Market Presence

Taj Pharma has established a strong footprint in Europe, Asia, Africa, Latin America, and the Middle East. By focusing on both regulated markets (EU, UK, Canada, Brazil, Germany, France) and semi-regulated/emerging economies, we deliver world-class pharmaceuticals that improve healthcare outcomes and patient well-being.


Taj Pharma continues to strengthen its reputation as a global leader in Oral Solid Dosage forms, backed by robust R&D capabilities, world-class manufacturing, and strategic collaborations. With a diversified portfolio covering CNS, Cardio-Metabolic, Gastroenterology, Gynecology, Pain Management, Glucocorticoids, and Antibiotics, Taj Pharma stands committed to delivering high-quality medicines that meet international standards and patient needs worldwide. Taj Pharma, an India-based multinational pharmaceutical company, has established itself as a trusted global partner in the development, manufacturing, and licensing of value-added Oral Solid Dosage (OSD) forms. With state-of-the-art R&D and manufacturing facilities in India and France, the company combines innovation, regulatory excellence, and operational efficiency to deliver high-quality, affordable, and patient-centric medicines worldwide.


Human Capital and Workforce Strength

At the core of Taj Pharma’s success is its highly skilled workforce of 500+ professionals, including:

  • Formulation scientists specializing in modified-release (MR), orally disintegrating tablets (ODT), and bioequivalent generics.
  • Process engineers experienced in granulation, compression, coating, and packaging.
  • Regulatory affairs experts with proven track records in dossier preparation for EMA, MHRA, ANVISA, GCC, and USFDA submissions.
  • Quality assurance (QA) and quality control (QC) teams maintaining strict compliance with WHO-GMP, PIC/S, and ISO 9001:2018 standards.

This multidisciplinary expertise allows Taj Pharma to accelerate product development cycles while maintaining highest international quality benchmarks.


Cutting-Edge R&D Capabilities

Taj Pharma’s R&D centers in India and France focus on value-added OSD innovations, addressing global market needs through:

  • Novel Drug Delivery Systems (NDDS): Development of ODT, sublingual tablets, sachets, and MR formulations for enhanced patient compliance.
  • Complex Formulations: Expertise in high-potency APIs (HPAPIs), multi-layer tablets, taste-masking technologies, and fixed-dose combinations (FDCs).
  • Bioequivalence (BE) Studies: Conducted in EU and India-based CROs for regulatory submissions across Europe, Canada, and LATAM.
  • Technology Transfer: Scalable processes enabling seamless tech transfer between R&D labs and large-scale manufacturing plants.

By integrating QbD (Quality by Design) principles, Taj Pharma ensures that products are robust, reproducible, and regulatory compliant.


Regulatory Compliance and Global Quality Standards

Taj Pharma’s manufacturing sites are certified by WHO-GMP, PIC/S, ISO 9001:2018, and compliant with ICH Q7, Q8, Q9, and Q10 guidelines.

  • Quality Management Systems (QMS): Implemented across all stages of raw material sourcing, in-process control, release testing, and stability monitoring.
  • Data Integrity: Adherence to ALCOA+ principles ensures reliability of analytical results for global dossier submissions.
  • Regulatory Documentation: Preparation of CTD/eCTD dossiers, CEP applications, and DMF filings, tailored to regional requirements.

This regulatory robustness allows Taj Pharma to register and commercialize products in regulated (EU, UK, Canada, Brazil, GCC) as well as semi-regulated and emerging markets.


Manufacturing Excellence in OSD Forms

Taj Pharma specializes in manufacturing a wide range of Oral Solid Dosage forms, supported by advanced infrastructure:

  • High-speed granulation and compression lines for tablets and capsules.
  • Fluid bed processors (FBP) and spray dryers for controlled particle engineering.
  • Film-coating and sugar-coating facilities for enhanced stability and compliance.
  • Blister packing (PVC, PVDC, Alu-Alu) and sachet filling lines for global distribution needs.
  • Dedicated containment areas for high-potency formulations ensuring safety and compliance.

Production adheres to cGMP guidelines, supported by real-time monitoring systems (SCADA, MES) and environmental controls (HVAC with HEPA filtration).


Therapeutic Focus and Portfolio Strength

Taj Pharma’s portfolio addresses critical therapeutic areas, offering both generic and branded formulations that meet international reference standards.

  1. CNS (Central Nervous System): Etifoxine, Trazodone, Zolpidem, Lisdexamphetamine
  2. Cardio-Metabolic: Fenofibrate formulations
  3. Gastroenterology: Esomeprazole, Mesalamine, Racecadotril, Ondansetron
  4. Gynecology: Secnidazole, Tranexamic Acid
  5. Pain & Anti-inflammatory: Ketorolac, Prednisolone
  6. Allergy & Immunology: Bilastine

These high-value, globally recognized molecules are marketed under both licensed brand equivalents and generic labels, supported by bioequivalence data and technology partnerships.


Strategic Collaborations and Licensing Partnerships

Taj Pharma has a proven record of collaboration with global pharmaceutical leaders, enabling co-marketing, licensing, and contract manufacturing.

  • Branded Equivalence: Development of OSD formulations equivalent to Bilaska®, Inexium®, Lipanthyl®, Josacine®, Zofren®, Stilnox®.
  • Technology Transfers: Smooth tech transfer agreements with European and LATAM partners.
  • CMO/CDMO Services: End-to-end contract manufacturing for regulated-market partners, from formulation to packaging and regulatory submission.

These alliances strengthen Taj Pharma’s position as a preferred partner for licensing and global distribution.


Global Reach and Market Access

Taj Pharma maintains a diversified market presence:

  • Regulated markets: France, UK, Germany, Canada, Brazil, GCC
  • Emerging markets: South Asia, Africa, CIS, LATAM

With proven supply chain reliability, Taj Pharma ensures timely product launches, competitive pricing, and consistent availability across geographies.


Taj Pharma has emerged as a progressive global MNC in the pharmaceutical industry, combining scientific expertise, world-class infrastructure, and regulatory compliance to deliver value-added Oral Solid Dosage forms. By leveraging its R&D in India and France, a workforce of 500+ specialists, and a diversified therapeutic portfolio, Taj Pharma continues to strengthen its reputation as a trusted partner for innovation, licensing, and manufacturing worldwide.